The GIP receptor component (absent in semaglutide) enhances lipolysis in visceral fat while suppressing hepatic de novo lipogenesis, the process by which the liver synthesizes triglycerides from excess carbohydrate intake
The two drugs target appetite through completely different pathwaysone stimulating the nervous system, the other activating peptide hormone pathways
USA 96 : 41314136 Hoshino T, Nakamura H, Okamoto M, Kato S, Araya S, Nomiyama K, Oizumi K, Young HA, Aizawa H and Yodoi J (2003) Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury
Semaglutide helps reduce how much food you want to eat and how often you feel hungry, while orlistat focuses on reducing how much fat your body absorbs from the food you do eat
(36999346) CRRT : No dose adjustment required